Document is current
Any future updates will be listed below
-
Authors
Wizel, Avishai
Spence, Matthew D. A.
Mints, Michael
Britton, William
Okolo, Ogoegbunam
Yu, Victoria
Cioffi, Isabel
Caruana, Salvatore
Troob, Scott H.
Faquin, William C.
Lin, Derrick T.
Tirosh, Itay
Puram, Sidharth V.
Parikh, Anuraag S.
Drier, Yotam
-
Funding
Funding for this research was provided by:
V Foundation
Cancer Research Foundation
Foundation for Barnes-Jewish Hospital
National Cancer Institute (1K08CA237732)
National Institute of Dental and Craniofacial Research (1K08DE033093)
H2020 European Research Council (949029)
Alon Fellowship of the Israeli Council for Higher Education
- License Information
-
More Information
Article History
Received: 4 May 2025
Accepted: 14 October 2025
First Online: 24 November 2025
Competing interests
: I.T. is a co-founder and adviser of Cellyrix Therapeutics and an adviser of Immunitas Therapeutics. All other authors declare no potential conflicts of interest.
